Dechra Pharmaceuticals PLC - DPH.L

DPH.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
DPH.L	0	0	0.1	2.1	1.8	27.8	2.4	55.5	469.4	3094.8
S&P 500	0.6	1.5	2.6	4.0	9.4	25.5	38.0	83.2	195.0	34364.2

Compare DPH.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	DPH.L
name	Dechra Pharmaceuticals PLC
price	3866
changes percentage	0.0518
change	2
day low	0
day high	3866
year high	4145.837
year low	0
market cap	4403605960
price avg 50	3828.32
price avg 200	3700.25
exchange	LSE
volume	192108
avg volume	1363899
open	None
previous close	3864
eps	-0.25
pe	-154.64
earnings announcement	2024-02-26T10:59:00.000+0000
shares outstanding	113906000
timestamp	2024-01-15 17:38:17

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 33.3%

Overall Quarterly Financial Health: 50.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0000000000
revenue	761500000	681800000	11.69
gross profit	426300000	384800000	10.78
gross profit ratio	0.56	0.56	-0.81
research and development expenses	60800000	36100000	68.42
operating expenses	420000000	214700000	95.62
interest income	800000	100000	700.00
interest expense	43900000	12200000	259.84
ebitda	98100000	253500000	-61.30
ebitdaratio	0.13	0.37	-65.35
operating income	6300000	95500000	-93.40
operating income ratio	0.01	0.14	-94.09
net income	-27900000	58200000	-147.94
net income ratio	-0.04	0.09	-142.92
eps	-0.24	0.54	-144.44

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 762 million in 2022 from 682 million in 2021 representing a change of 11.69%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 426 million in 2022 from 385 million in 2021 representing a change of 10.78%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 61 million in 2022 from 36 million in 2021 representing a change of 68.42%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 98 million in 2022 from 254 million in 2021 representing a change of -61.3%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 420 million in 2022 from 215 million in 2021 representing a change of 95.62%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 6 million in 2022 from 96 million in 2021 representing a change of -93.4%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -28 million in 2022 from 58 million in 2021 representing a change of -147.94%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.24 in 2022 from -0.24 in 2021 representing a change of -144.44%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2022Q4	2022Q2	Q/Q change %
0000000000
revenue	384100000	377400000	1.78
gross profit	211100000	218500000	-3.39
gross profit ratio	0.55	0.58	-5.07
research and development expenses	62400000	28200000	121.28
operating expenses	263500000	179900000	46.47
interest income	13400000	8900000	50.56
interest expense	13400000	8900000	50.56
ebitda	6700000	55500000	-87.93
ebitdaratio	0.02	0.15	-88.14
operating income	-29800000	46900000	-163.54
operating income ratio	-0.08	0.12	-162.43
net income	-50500000	22600000	-323.45
net income ratio	-0.13	0.06	-319.55
eps	-0.44	0.2	-321.55

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 384 million in 2022Q4 from 377 million in 2022Q2 representing a change of 1.78%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 62 million in 2022Q4 from 28 million in 2022Q2 representing a change of 121.28%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 7 million in 2022Q4 from 56 million in 2022Q2 representing a change of -87.93%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 211 million in 2022Q4 from 218 million in 2022Q2 representing a change of -3.39%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 264 million in 2022Q4 from 180 million in 2022Q2 representing a change of 46.47%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to -30 million in 2022Q4 from 47 million in 2022Q2 representing a change of -163.54%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -50 million in 2022Q4 from 23 million in 2022Q2 representing a change of -323.45%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.44 in 2022Q4 from -0.44 in 2022Q2 representing a change of -321.55%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0000000000
total assets	1569400000	1293300000	21.35
total liabilities	814200000	626500000	29.96
total equity	755200000	666800000	13.26
cash and cash equivalents	74400000	120900000	-38.46
short term investments	0	0	NaN
long term investments	14900000	15800000	-5.70
total current assets	467900000	444400000	5.29
total non current assets	1101500000	848900000	29.76
total current liabilities	164000000	158700000	3.34
total non current liabilities	650200000	467800000	38.99
common stock	1100000	1100000	0.00
retained earnings	86600000	164000000	-47.20
total debt	504500000	329100000	53.30

Overall Score of Annual Balance Sheet

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,569 million in 2022 from 1,293 million in 2021 representing a change of 21.35%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 755 million in 2022 from 667 million in 2021 representing a change of 13.26%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 468 million in 2022 from 444 million in 2021 representing a change of 5.29%. This indicates a better liquidity position.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 814 million in 2022 from 626 million in 2021 representing a change of 29.96%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 74 million in 2022 from 121 million in 2021 representing a change of -38.46%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 164 million in 2022 from 159 million in 2021 representing a change of 3.34%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to 87 million in 2022 from 164 million in 2021 representing a change of -47.2%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 504 million in 2022 from 329 million in 2021 representing a change of 53.3%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2022Q4	2022Q2	Q/Q change %
0000000000
total assets	1569400000	1744300000	-10.03
total liabilities	814200000	902600000	-9.79
total equity	755200000	841700000	-10.28
cash and cash equivalents	74400000	87900000	-15.36
short term investments	0	0	NaN
long term investments	14900000	15400000	-3.25
total current assets	467900000	459300000	1.87
total non current assets	1101500000	1285000000	-14.28
total current liabilities	164000000	168400000	-2.61
total non current liabilities	650200000	734200000	-11.44
common stock	1100000	1100000	0.00
retained earnings	86600000	151000000	-42.65
total debt	504500000	511200000	-1.31

Overall Score of Quarterly Balance Sheet

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,569 million in 2022Q4 from 1,744 million in 2022Q2 representing a change of -10.03%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 755 million in 2022Q4 from 842 million in 2022Q2 representing a change of -10.28%. This indicates a decrease in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 74 million in 2022Q4 from 88 million in 2022Q2 representing a change of -15.36%. This indicates a decrease in available liquid assets.

  Retained Earnings: Retained Earnings decreased to 87 million in 2022Q4 from 151 million in 2022Q2 representing a change of -42.65%. This indicates an accumulated losses.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 814 million in 2022Q4 from 903 million in 2022Q2 representing a change of -9.79%. This indicates a decrease in overall liabilities.

  Total Current Assets: Total Current Assets increased to 468 million in 2022Q4 from 459 million in 2022Q2 representing a change of 1.87%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 164 million in 2022Q4 from 168 million in 2022Q2 representing a change of -2.61%. This indicates a lower short-term debt burden.

  Total Debt: Total Debt decreased to 504 million in 2022Q4 from 511 million in 2022Q2 representing a change of -1.31%. This indicates a reduction in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2022	2021	Y/Y change %
0000000000
net change in cash	-46500000	2500000	-1960.00
operating cash flow	63600000	122900000	-48.25
free cash flow	33300000	45300000	-26.49
capital expenditure	-30300000	-77600000	60.95
depreciation and amortization	89700000	89100000	0.67
deferred income tax	10600000	-39600000	126.77
stock based compensation	-800000	3300000	-124.24
accounts payables	0	0	NaN
inventory	-31100000	-19300000	-61.14
acquisitions net	-396900000	-800000	-49512.50
investments in property plant and equipment	-30300000	-77600000	60.95
net cash used for investing activites	-426200000	-78300000	-444.32
debt repayment	0	0	NaN
common stock issued	181900000	2300000	7808.70
common stock repurchased	-15100000	3600000	-519.44
dividends paid	-51700000	-44800000	-15.40
net cash used provided by financing activities	316500000	-46100000	786.55
cash at end of period	74400000	120900000	-38.46
accounts receivables	-21500000	-23400000	8.12
cash at beginning of period	120900000	118400000	2.11

Overall Score of Annual Cashflow Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -46 million in 2022 from 2 million in 2021 representing a change of -1960.0%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 64 million in 2022 from 123 million in 2021 representing a change of -48.25%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 33 million in 2022 from 45 million in 2021 representing a change of -26.49%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -30 million in 2022 from -78 million in 2021 representing a change of 60.95%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 11 million in 2022 from -40 million in 2021 representing a change of 126.77%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to -22 in 2022 from -23 million in 2021 representing a change of 8.12%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -52 million in 2022 from -45 million in 2021 representing a change of -15.4%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to -1 million in 2022 from 3 million in 2021 representing a change of -124.24%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2022Q4	2022Q2	Q/Q change %
0000000000
operating cash flow	12100000	51500000	-76.50
free cash flow	-200000	41000000	-100.49
capital expenditure	-12300000	-10500000	-17.14
depreciation and amortization	41100000	8600000	377.91
deferred income tax	46400000	7000000	562.86
stock based compensation	-2600000	1800000	-244.44
accounts receivables	-42100000	20600000	-304.37
accounts payables	0	0	NaN
inventory	-1700000	-29400000	94.22
acquisitions net	0	0	NaN
investments in property plant and equipment	-12300000	-10500000	-17.14
net cash used for investing activites	-18000000	-408200000	95.59
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-14300000	-37400000	61.76
net cash used provided by financing activities	-4900000	321400000	-101.52
net change in cash	-6750000	-16500000	59.09
cash at end of period	-6750000	-16500000	59.09
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -7 million in 2022Q4 from -16 million in 2022Q2 representing a change of 59.09%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure decreased to -12 million in 2022Q4 from -10 million in 2022Q2 representing a change of -17.14%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to -3 million in 2022Q4 from 2 million in 2022Q2 representing a change of -244.44%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Receivables: Accounts Receivables decreased to -42 million in 2022Q4 from 21 million in 2022Q2 representing a change of -304.37%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -14 million in 2022Q4 from -37 million in 2022Q2 representing a change of 61.76%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 12 million in 2022Q4 from 52 million in 2022Q2 representing a change of -76.5%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 0 million in 2022Q4 from 41 million in 2022Q2 representing a change of -100.49%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Deferred Income Tax: Deferred Income Tax increased to 46 million in 2022Q4 from 7 million in 2022Q2 representing a change of 562.86%. This indicates that the company's tax liability for future periods has increased.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-06-30	2022-06-30	Y/Y change %
FY
calendar year	2022	2021	NaN
revenue per share	6.71	6.29	6.63
net income per share	-0.25	0.54	-145.77
operating cash flow per share	0.56	1.13	-50.60
free cash flow per share	0.29	0.42	-29.82
cash per share	0.66	1.12	-41.25
book value per share	6.66	6.16	8.12
tangible book value per share	-1.47	-0.59	-150.58
shareholders equity per share	6.66	6.16	8.12
interest debt per share	4.83	3.15	53.40
market cap	4182744121.74	3746140720.14	11.65
enterprise value	4612844121.74	3954340720.14	16.65
pe ratio	-149.92	64.37	-332.91
price to sales ratio	5.49	5.49	-0.03
pocfratio	65.77	30.48	115.76
pfcf ratio	125.61	82.7	51.89
pb ratio	5.54	5.62	-1.42
ptb ratio	5.54	5.62	-1.42
ev to sales	6.06	5.8	4.44
enterprise value over ebitda	47.02	15.6	201.44
ev to operating cash flow	72.53	32.18	125.42
ev to free cash flow	138.52	87.29	58.69
earnings yield	-0.01	0.02	-142.93
free cash flow yield	0.01	0.01	-34.16
debt to equity	0.67	0.49	35.35
debt to assets	0.32	0.25	26.33
net debt to ebitda	4.38	0.82	433.82
current ratio	2.85	2.8	1.89
interest coverage	0.14	7.83	-98.17
income quality	10.1	1.29	684.46
dividend yield	0.01	0.01	3.36
payout ratio	-1.85	0.77	-340.73
sales general and administrative to revenue	0.47	0.26	80.07
research and ddevelopement to revenue	0.08	0.05	50.79
intangibles to total assets	0.59	0.56	4.06
capex to operating cash flow	0.48	0.63	-24.55
capex to revenue	0.04	0.11	-65.04
capex to depreciation	0.34	0.87	-61.21
stock based compensation to revenue	-0.0	0.0	-121.71
graham number	6.07	8.63	-29.66
roic	0.0	0.07	-94.63
return on tangible assets	-0.04	0.1	-141.70
graham net net	-4.61	-3.01	-53.07
working capital	303900000	285700000	6.37
tangible asset value	-167200000	-63700000	-162.48
net current asset value	-346300000	-182100000	-90.17
invested capital	1385600000	1116500000	24.10
average receivables	133150000	105150000	26.63
average payables	140650000	125150000	12.39
average inventory	196500000	162600000	20.85
days sales outstanding	69.12	65.37	5.74
days payables outstanding	157.35	168.12	-6.41
days of inventory on hand	236.62	215.93	9.58
receivables turnover	5.28	5.58	-5.43
payables turnover	2.32	2.17	6.85
inventory turnover	1.54	1.69	-8.74
roe	-0.04	0.09	-142.33
capex per share	0.27	0.72	-62.72

• Negative

  ROE: Return on Equity (ROE) decreased to -0.04 on 2023-06-30 from 0.09 on 2022-06-30, representing a change of -142.33%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -149.92 on 2023-06-30 from 64.37 on 2022-06-30, representing a change of -332.91%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 2.85 on 2023-06-30 from 2.80 on 2022-06-30, representing a change of 1.89%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.67 on 2023-06-30 from 0.49 on 2022-06-30, representing a change of 35.35%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2023-06-30 Q4	2023-03-31 Q3	Q/Q change %
DPH.L
calendar year	2022	2022	NaN
revenue per share	1.69	1.69	0.47
net income per share	-0.22	-0.22	-0.47
operating cash flow per share	0.05	0.05	0.47
free cash flow per share	-0.0	-0.0	-0.47
cash per share	0.66	0.65	0.47
book value per share	6.67	6.63	0.47
tangible book value per share	-1.48	-1.42	-3.63
shareholders equity per share	6.67	6.63	0.47
interest debt per share	4.51	4.34	3.90
market cap	4176438960.72	3016685588	38.44
enterprise value	4606538960.72	2942285588	56.56
pe ratio	-41.35	-29.87	-38.44
price to sales ratio	21.75	15.71	38.44
pocfratio	690.32	498.63	38.44
pfcf ratio	-41764.39	-30166.86	-38.44
pb ratio	5.53	3.99	38.44
ptb ratio	5.53	3.99	38.44
ev to sales	23.99	15.32	56.56
enterprise value over ebitda	1375.09	878.29	56.56
ev to operating cash flow	761.41	486.33	56.56
ev to free cash flow	-46065.39	-29422.86	-56.56
earnings yield	-0.01	-0.01	27.77
free cash flow yield	-0.0	-0.0	27.77
debt to equity	0.67	0.65	3.47
debt to assets	0.32	0.31	3.47
net debt to ebitda	128.39	-22.21	678.09
current ratio	2.85	2.85	0.00
interest coverage	-2.22	-2.22	0.00
income quality	-0.24	-0.24	0.00
dividend yield	0.0	0.0	-27.77
payout ratio	-0.28	-0.28	0.00
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.16	0.16	0.00
intangibles to total assets	0.59	0.58	0.56
capex to operating cash flow	1.02	1.02	0.00
capex to revenue	0.03	0.03	0.00
capex to depreciation	0.3	0.3	0.00
stock based compensation to revenue	-0.01	-0.01	0.00
graham number	5.78	5.75	0.47
roic	-0.01	-0.01	1.34
return on tangible assets	-0.04	-0.04	-0.79
graham net net	-4.62	-4.59	-0.47
working capital	303900000	303900000	0.00
tangible asset value	-167200000	-162100000	-3.15
net current asset value	-346300000	-346300000	0.00
invested capital	1385600000	1380500000	0.37
average receivables	144200000	135050000	6.78
average payables	93950000	91350000	2.85
average inventory	217300000	220550000	-1.47
days sales outstanding	67.58	67.58	0.00
days payables outstanding	150.35	45.16	232.95
days of inventory on hand	226.09	226.09	0.00
receivables turnover	1.33	1.33	0.00
payables turnover	0.6	1.99	-69.97
inventory turnover	0.4	0.4	0.00
roe	-0.03	-0.03	0.00
capex per share	0.05	0.05	0.47

• Negative

  ROE: Return on Equity (ROE) decreased to -0.03 on 2023-06-30 Q4 from -0.03 on 2023-03-31 Q3, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -41.35 on 2023-06-30 Q4 from -29.87 on 2023-03-31 Q3, representing a change of -38.44%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.85 on 2023-06-30 Q4 from 2.85 on 2023-03-31 Q3, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.67 on 2023-06-30 Q4 from 0.65 on 2023-03-31 Q3, representing a change of 3.47%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None